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ABSTRACT
Objectives To evaluate the extent to which intensive care
units participating in the initial Keystone ICU project
sustained reductions in rates of catheter related
bloodstream infections.
Design Collaborative cohort study to implement and
evaluate interventions to improve patients’ safety.
Setting Intensive care units predominantly in Michigan,
USA.
Intervention Conceptual model aimed at improving
clinicians’ use of five evidence based recommendations
toreduceratesofcatheterrelatedbloodstreaminfections
rates, with measurement and feedback of infection rates.
Duringthesustainabilityperiod,intensivecareunitteams
were instructed to integrate this intervention into staff
orientation, collect monthly data from hospital infection
control staff, and report infection rates to appropriate
stakeholders.
MainoutcomemeasuresQuarterlyrateofcatheterrelated
bloodstreaminfectionsper1000catheterdaysduringthe
sustainabilityperiod(19-36monthsafterimplementation
of the intervention).
Results Ninety (87%) of the original 103 intensive care
units participated, reporting 1532 intensive care unit
months of data and 300310 catheter days during the
sustainability period. The mean and median rates of
catheter related bloodstream infection decreased from
7.7and2.7(interquartilerange0.6-4.8)atbaselineto1.3
and 0 (0-2.4) at 16-18 months and to 1.1 and 0 (0.0-1.2)
at 34-36 months post-implementation. Multilevel
regression analysis showed that incidence rate ratios
decreased from 0.68 (95% confidence interval 0.53 to
0.88) at 0-3 months to 0.38 (0.26 to 0.56) at
16-18 months and 0.34 (0.24-0.48) at 34-36 months
post-implementation. During the sustainability period,
the mean bloodstream infection rate did not significantly
change from the initial 18 month post-implementation
period (−1%, 95% confidence interval −9% to 7%).
Conclusions The reduced rates of catheter related
bloodstream infection achieved in the initial 18 month
post-implementation period were sustained for an
additional18monthsasparticipatingintensivecareunits
integratedtheinterventionintopractice.Broaduseofthis
intervention with achievement of similar results could
substantially reduce the morbidity and costs associated
with catheter related bloodstream infections.
INTRODUCTION
Catheter related bloodstream infections cause consid-
erablemorbidity,mortality,andhealthcarecosts.
12An
estimated 82000 catheter related bloodstream infec-
tions and up to 28000 attributable deaths occur in
intensive care units annually,
3 and each infection
costsabout$45000 (£28000;€31000).
4Inanongoing
quality improvement project, known as the Michigan
Health & Hospital Association (MHA) Keystone ICU
project, these infections were substantially reduced in
103 participating intensive care units.
5 The median
infection rate per 1000 catheter days dropped from
2.7 at baseline to 0 within three months after imple-
mentationofanevidencebasedintervention.Eighteen
months after implementation, infection rates had
decreased by 66% from baseline. However, whether
these initial results were sustained was not known.
Limitedevidenceassessingthesustainabilityofqual-
ityimprovementprojectsbeyondtheinitialimplemen-
tationandevaluationperiodisavailable.
67Toevaluate
sustainability, a quality improvement project must
have an adequate infrastructure to sustain activities
beyonditsinitialphase.Afterthe18monthpost-imple-
mentationevaluationperiod,mosthospitalsparticipat-
ing in the Keystone ICU project continued to submit
data on infection rates. The objective of this study was
toevaluatetheextenttowhichintensivecareunitspar-
ticipatingintheinitialKeystoneICUprojectsustained
reductions in rates of catheter related bloodstream
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tion rate would remain low during the sustainability
period relative to baseline.
METHODS
Study design
The Keystone ICU project was designed as a prospec-
tivecohortstudyandusedacollaborativemodelinvol-
ving the Johns Hopkins Quality and Safety Research
Group, the MHA Keystone Center for Patient Safety
and Quality, and participating hospitals. All hospitals
in Michigan with an intensivecare unit were invited to
participate in the project. To participate, they had to
form an intensive care unit team, agree to complete
the project work, and send a signed letter of commit-
ment from a senior hospital executive with a list of
teammembers.Ataminimum,theteamhadtoinclude
a senior executive, the intensive care unit director and
nursemanager,andaphysicianandnursein theinten-
sive care units who could both dedicate 20% of their
effort to project activities. The initial implementation
and evaluation phase was funded by the Agency for
Healthcare Research and Quality. During this phase,
individual intensive care units implemented two cul-
tural interventions first and then two interventions tar-
geting patients’ safety (in any order).
5 The four
interventions were implemented at three month inter-
vals. As a result, the intervention targeting catheter
related bloodstream infection had a staggered timing
for its implementation.
At the end of the initial funding, intensive care unit
teamswereinstructedtosustainthebloodstreaminfec-
tion intervention. They were to maintain a team, inte-
grate the intervention into staff orientation, continue
collecting monthly data on catheter related blood-
stream infections and catheter days in collaboration
with hospital infection control staff, and continue
reporting infection rates per 1000 catheter days to
appropriate stakeholders. We lacked funding to
formallyevaluateanyintensivecareunits’compliance
with each of these components. Informally, however,
nearlyallunitsreportedthattheywerecontinuingallof
these components. After the initial funding ended,
intensive care units paid MHA to continue working
with the Johns Hopkins team on new quality improve-
ment interventions not related to catheter related
bloodstream infections. Thirteen intensive care units
declined further participation specifically because of
the MHA fee. Compared with all intensive care units
thatcontinuedtoparticipate,the13units thatdropped
out of this project were more likely to be at a teaching
hospital (93% v 65 %, P=0.04), but they did not vary in
the median number of hospital beds (383 v 338,
P=0.70) and did not have significantly different rates
of catheter related bloodstream infection in the first
and final quarters of the initial 18 month post-imple-
mentation period or quarterly rates of improvement
over that period.
Intervention
We used a conceptual model to increase use of evi-
dence based interventions and improve safety culture.
This model has been described elsewhere.
8-10 The
interventionevaluatedinthisstudytargetedclinicians’
useoffiveevidencebasedrecommendationstoreduce
catheter related bloodstream infections from the Cen-
tersforDiseaseControlandPrevention(CDC).
25Four
recommendations related to insertion of the catheter:
hand washing, using full barrier precautions, cleaning
the skin with chlorhexidine, and avoiding the femoral
site when possible. The fifth recommendation was to
remove unnecessary catheters. Strategies to increase
the use of these evidence based recommendations are
described elsewhere.
511 Teams reported all catheter
related bloodstream infections and number of days of
use of catheters (catheter days). For the remainder of
thispaperwewillusethetermbloodstreaminfectionto
indicate catheter related bloodstream infection.
Outcomes
The primary outcome was the quarterly rate of blood-
stream infections during the 18 month sustainability
period. To test sustainability of the intervention, we
analysed trends in infection rates for the 18 month
initial evaluation period compared with the 18 month
sustainability period. Specifically, a total of 103 inten-
sivecareunitsfrom67hospitalscontributeddatatothe
initialevaluation period.Someintensivecareunitsdid
not contribute to all time periods, and 13 of the 103
units declined to participate in the sustainability per-
iod,leaving90forwhichweevaluatedtheprimaryout-
come. All hospitals used standard definitions of
catheter related bloodstream infections provided by
the CDC.
12 Our analysis included hospital teaching
status (binary variable) and bed size (continuous vari-
able) to show any effect on distribution of catheter
days. Thesevariablescame from the American Hospi-
tal Association database.
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Catheter related bloodstream infection rate as a function of time. Circles represent mean
infection rate per quarter; thick blue line represents estimated mean rate of infection modelled
as a linear-spline function in which rate of change in mean infection rate is allowed to change
after 16-18 month period; thin red lines represent changes in observed infection rates over
time within a random sample of 50 intensive care units
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Wesummarisedratesofbloodstreaminfectionasmed-
ians and interquartile ranges and as means and stan-
dard deviations. We used generalised linear latent
and mixed models,
1314 with a Poisson distribution, to
comparethequarterlybloodstreaminfectionratefrom
baseline to the end of the initial 16-18 month evalua-
tion period and for the subsequent 18 month sustain-
ability period (from 19-21 months to 33-36 months
post-implementation). In the models, we used robust
estimation of variance, adjusted for hospital teaching
statusandbednumber,andincludedtwolevelrandom
effects to account for nested clustering within the
data
1315: intensive care units over time and hospitals
within regions. We also evaluated whether the relative
changeinquarterlybloodstreaminfectionratewasdif-
ferent during the initial evaluation period compared
with the sustainability period by using a linear spline
model, which allowed the relative change in quarterly
infection rate to change at the end of the initial
18 month period.
16
Toassessthesensitivityofourresultstomissingdata
and to potential non-reporting bias, we replicated the
analysis including only those 43 intensive care units
that reported continuous data from baseline to the
end of the sustainability period. To assess the sensitiv-
ity of our results to a few units that reported quarters
with large rates of bloodstream infections (primarily
driven by small numbers of catheter days), we repli-
cated the analysis excluding the quarters of data in
which catheter days were in the lowest 10% across all
quarters. Finally, we replicated our models assuming
an over-dispersed Poisson distribution (known as a
negative binomial distribution) for the number of
bloodstream infections to assess the sensitivity of our
results to the Poisson assumption. All P values are two
sided; we considered a P value of ≤0.05 to be statisti-
callysignificant.WeusedStata(version9.1)forallana-
lyses.
RESULTS
During the sustainability period, 90 (87%) of the origi-
nal 103 intensive care units from 61 (91%) of the origi-
nal 67 hospitals reported 1532 intensive care unit
months of data and 300310 catheter days. Thirteen
units dropped out because they chose not to pay the
MHA’s fee. The distribution of total catheter days by
hospitalteachingstatusandbednumberwasconsistent
between the initial evaluation period and the sustain-
ability period (table 1).
Overall, 1394 possible quarters of bloodstream
infection data existed for the entire study (baseline
data for 55 intensive care units, plus 13 subsequent
quarters for the three month implementation period
and the 36 month post-implementation period for
103 units) (table 2). Seventy-eight quarters (roughly
5%) of data were lost when the 13 units left the colla-
boration,and65quarters(roughly5%)ofbloodstream
infection rates were missing for the remaining units.
Total catheter days were consistent during each
quarter in the initial evaluation period and the sustain-
ability period. The mean and median rates of blood-
stream infection decreased from 7.7 and 2.7
(interquartile range 0.6-4.8) per 1000 catheter days at
baselineto2.3and0(0.0-3.0)at0-3monthsafterimple-
mentationoftheinterventionandto1.3and0(0-2.4)at
16-18monthsafterimplementation,andtheyweresus-
tained at 1.1 and 0 (0.0-1.2) at 34-36 months post-
implementation (table 2). The multilevel Poisson
regression model showed a significant decrease in
bloodstream infection rates during all study periods
compared with baseline rates; incidence rate ratios
decreased from 0.68 (95% confidence interval 0.53 to
0.88) at 0-3 months to 0.38 (0.26 to 0.56) at
16-18 months after implementation, with a sustained
improvement of 0.34 (0.24 to 0.48) at 34-36 months
(table 2).
Frombaselineto the endof the initial 18montheva-
luation period, the mean rate of bloodstream infection
decreased significantly by 12% (95% confidence inter-
val 9% to 15%) per quarter (figure). During the
19-36monthsustainabilityperiod,thequarterlyblood-
stream infection rate did not significantly change from
the rate achieved at the end of the initial evaluation
period (1% decrease, 95% confidence interval 9%
decrease to 7% increase).
Forty-three intensive care units reported data con-
tinuously from baseline to the end of the sustainability
Table 1 |Number of intensive care units (ICUs) and catheter days by hospital type and size for each study period
Hospital type/size
Baseline period before
implementation of intervention
During implementation of
intervention (3 months)
Initial evaluation period
(18 months)
Sustainability period
(18 months)
No of ICUs* Catheter days (%) No of ICUs Catheter days (%) No of ICUs Catheter days (%) No of ICUs Catheter days (%)
All hospitals 55 41 506 (100) 96 57 033 (100) 103 300 175 (100) 90 300 310 (100)
Teaching status:
Teaching 33 29 407 (71) 66 44 752 (78) 71 231 595 (77) 60 230 836 (77)
Non-teaching 22 12 099 (29) 30 12 281 (22) 32 68 580 (23) 30 69 474 (23)
No of beds:
<200 13 3 266 (8) 17 3 066 (5) 19 16 349 (5) 17 16 398 (5)
200-299 12 13 321 (32) 19 10 792 (19) 23 67 970 (23) 22 59 122 (20)
300-399 12 10 531 (25) 20 12 314 (22) 20 66 765 (22) 17 63 650 (21)
≥400 18 14 388 (35) 40 30 861 (54) 41 149 091 (50) 34 161 140 (54)
*Of 103 ICUs participating in initial evaluation, 48 did not contribute baseline data—40 implemented intervention during baseline period of study; 8 did not report baseline data.
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units resulted in similar findings to our main analysis
including all units: an estimated 13% (9% to 16%)
decrease in the mean rate of bloodstream infection
per quarter during the initial evaluation period fol-
lowed by a less than 1% decrease (4% decrease to 5%
increase) per quarter during the sustainability period.
The primary results were not substantially changed by
exclusion of infection data for quarters in which the
total catheter days were in the lowest 10% (<67 days).
Finally, the results changed little when we used regres-
sion models assuming an over-dispersed Poisson dis-
tribution for the number of infections.
DISCUSSION
Our findings show that the markedly reduced rates of
bloodstream infection achieved in the initial evalua-
tionperiodoftheKeystoneICUprojectweresustained
for an additional 18 months. The median rate of infec-
tion remained at zero for the entire 18 month sustain-
ability period, with a greater than 60% reduction in
infectionratesfrombaselinesustainedattheendofthe
36 month period.
Ourprojectisoneofrelativelyfewrobustlydesigned
and evaluated large scale quality improvement pro-
jects that have shown substantial improvements.
Even fewer projects have evaluated the sustainability
of such results. Achieving sustainability has been a
major challenge for the quality improvement
field.
17-19 The Keystone ICU project coupled a formal
model to translate evidence into practice with a com-
prehensive patient safety intervention to improve cul-
ture, educate staff, learn from mistakes, and involve
senior leaders.
810 During interviews, intensive care
unit teams noted several factors that were important
in sustaining this project, including continued feed-
back of infection data that the team perceived as
valid, improvements in safety culture that occurred as
part of the overall Keystone ICU project, an unremit-
ting belief in the preventability of bloodstream infec-
tions, involvement of senior leaders who reviewed
infection data and provided teams with the resources
needed,and a shared goal ratherthana competition to
reduce infection rates throughout the state of Michi-
gan. Other studies describe similar methods to facili-
tate sustainability, such as active support from leaders
and an infrastructure that supports quality improve-
ment methods, training of staff, involving key internal
and external stakeholders,
620-23 alignment of project
andorganisationalgoals,
21multidisciplinaryteamsand
collaborations,
6 and inclusion of change management
that also encourages local adaptation and rewards
innovation and change.
21 Quality improvement initia-
tives that demonstrate value are more likely to be
sustained.
2124 We did not formally evaluate the factors
associated with continued improvement. However,
the quality improvement model used in the Keystone
ICU project and our recommendations to teams at the
end of the initial evaluation period to maintain a team,
orientnewstaff,collectmonthlydata,andreportinfec-
tion rates to appropriate stakeholders target many of
the recommendations described in the literature.
Limitations of study
This research has several new limitations not reported
in our evaluation of the initial evaluation period.
5
Table 2 |Catheter related bloodstream infection rates from baseline until 36 months after quality improvement intervention
Study period No of ICUs
Median (IQR) No of
infections Median (IQR) catheter days
Infection rate
Incidence rate ratio* (95% CI) Median (IQR) Mean (SD)
Baseline 55 2 (1-3) 551 (220-1091) 2.7 (0.6-4.8) 7.7 (28.9) Reference
During implementation 96 1 (0-2) 447 (237-710) 1.6 (0-4.4) 2.8 (4.0) 0.81 (0.61 to 1.08)
After implementation—initial
evaluation period:
0-3 months 95 0 (0-2) 436 (246-771) 0 (0-3.0) 2.3 (4.0) 0.68 (0.53 to 0.88)
4-6 months 95 0 (0-1) 460 (228-743) 0 (0-2.7) 1.8 (3.2) 0.62 (0.42 to 0.90)
7-9 months 96 0 (0-1) 467 (252-725) 0 (0-2.0) 1.4 (2.8) 0.52 (0.38 to 0.71)
10-12 months 95 0 (0-1) 431 (249-743) 0 (0-2.1) 1.2 (1.9) 0.48 (0.33 to 0.70)
13-15 months 95 0 (0-1) 404 (158-695) 0 (0-1.9) 1.5 (4.0) 0.48 (0.31 to 0.76)
16-18 months 95 0 (0-1) 367 (177-682) 0 (0-2.4) 1.3 (2.4) 0.38 (0.26 to 0.56)
After implementation—
sustainability period:
19-21 months 89 0 (0-1) 399 (230-680) 0 (0-1.4) 1.8 (5.2) 0.34 (0.23 to 0.50)
22-24 months 89 0 (0-1) 450 (254-817) 0 (0-1.6) 1.4 (3.5) 0.33 (0.23 to 0.48)
25-27 months 88 0 (0-1) 481 (266-769) 0 (0-2.1) 1.6 (3.9) 0.44 (0.34 to 0.57)
28-30 months 90 0 (0-1) 479 (253-846) 0 (0-1.6) 1.3 (3.7) 0.40 (0.30 to 0.53)
31-33 months 88 0 (0-1) 495 (265-779) 0 (0-1.1) 0.9 (1.9) 0.31 (0.21 to 0.45)
34-36 months 85 0 (0-1) 456 (235-787) 0 (0-1.2) 1.1 (2.7) 0.34 (0.24 to 0.48)
ICU=intensive care units; IQR=interquartile range.
*Calculated with use of generalised linear latent and mixed model,
13 with robust variance estimation and random effects to account for clustering of catheter related bloodstream infections
within ICUs over time and clustering of hospitals within geographical regions; rates of catheter related bloodstream infections during implementation, initial evaluation, and sustainability
periods compared with baseline (pre-implementation) values, adjusted for hospital’s teaching status and number of beds.
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have been sustainable if intensive care units were
blinded to their infection rates, because our model to
change practice included feedback of data so units
could evaluate their performance.
8 Secondly, we had
insufficient funds to formally evaluate mechanisms
that contributed to the success of this sustainability,
so we cannot evaluate the relative importance during
the sustainability phase of periodic meetings between
participatingunitsandtheKeystoneCenter.Although
these meetings focused on implementing new safety
interventions, they may have influenced the sustain-
ability of the bloodstream infection intervention. Also
unknown was the impact of Blue Cross Blue Shield of
Michigan’s quality payment incentive on a hospital’s
decisiontocontinuetoparticipateintheKeystoneICU
project.Inthefirstyear,hospitalsreceivedanincentive
payment if they submitted 90% of the required blood-
stream infection data. In subsequent years, the incen-
tive payment was based on performance thresholds
(statewide infection rate compared against CDC
pooled mean) for continued reduction of infection
rates. Thirdly, we did not evaluate the use of new tech-
nologies, such as impregnated dressings or catheters
and chlorhexidine baths, on rates of infection.
25-28
Implications and future research
These findings have important public health conse-
quences. If the multifaceted quality improvement
intervention and collaborative model were implemen-
ted in all intensive care units across the United States,
andtheresultsweresimilartothoseachievedinMichi-
gan, substantial and persistent reductions could be
made in the 82000 infections, 28000 deaths, and
$2.3 billion costs attributed to these infections
annually.
3 Moreover, the use of this quality improve-
mentmodeltoreduceothercomplicationsmayfurther
improve quality and reduce costs of care.
Aprominentitemontheresearchagendaforquality
improvement initiatives is identifying methods that
sustain a successful project. Sustainability is often
vague and may not be formally separated from the
initial implementation and evaluation of the project.
22
Althoughwedonothaveempiricaldatatosupportthis
statement,bothourexperienceandtheoreticalreasons
supporttheideathatsustainabilityshouldbeexamined
separately from implementation. Weick and Quinn
noted that organisations and teams vary in whether
they are best suited for episodic or continuous
change.
29Moreover,early,mid,andlateimplementers
have differing characteristics and motivations for
implementing quality improvement interventions.
30
Someimplementersfocuseffortsonshorttermresults,
whereas sustainers generally focus on long term
results. Teams that are good “implementers” may not
be the same as those that are good “sustainers.” More
research is needed to better understand when imple-
mentation ends and sustaining begins, as well as the
attributes of teams that are good implementers and
good sustainers.
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